Multiple myeloma, a neoplasm of plasma cells, accounts for∼∼ 15% of
lymphatohematopoietic cancers (LHC) and 2% of all cancers in the US. Incidence rates …

The aim of the present work was to perform a meta-analysis to evaluate the association
between the interleukin 10 (IL-10)− 819C/T (rs1800871) polymorphism and cancer risk. A …

IL-6 is critical for tumorigenesis. However, previous studies on the association of IL-6
promoter polymorphisms with predisposition to different cancer types are somewhat …

A good number of genome-wide association studies (GWAS), including meta-analyses,
reported that single nucleotide polymorphisms (SNPs) of the IL-6 gene are significantly …

Multicentric Castleman Disease is largely driven by increased signaling in the pathway for
the plasma cell growth factor interleukin-6. We hypothesized that interleukin-6/interleukin-6 …

Many molecular epidemiologic studies have shown that interleukin-6 (IL-6) polymorphisms
are significantly associated with susceptibility for various cancers. However, the conclusions …

Abstract Interleukin-6 (IL-6) plays a contributory role in the progression and severity of many
forms of cancer; it however remains unclear whether the relevance between circulating IL-6 …

Abstract Interleukin-6 (IL-6) promotes normal plasma cell development and proliferation of
myeloma cells in culture. We evaluated IL-6 genotypes and body mass index (BMI) in a case …

Interleukin-10 (IL-10) is a multifunctional cytokine which participates in the development and
progression of various malignant tumors. To date, a number of case–control studies were …

Sickle cell anemia (SCA), a disorder characterized by both acute and chronic inflammation,
exhibits substantial phenotypic variability. Interleukin-1 beta (IL-1β) and IL-6 are important in …